MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | - | ₹1.45 Cr | ₹1.45 Cr | ₹20 Cr | ₹48 Cr |
What is the latest Contingent Liabilities ratio of MARKSANS PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2024 | - |
Mar2023 | ₹1.45 Cr |
Mar2022 | ₹1.45 Cr |
Mar2021 | ₹20 Cr |
Mar2020 | ₹48 Cr |
How is Contingent Liabilities of MARKSANS PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | -100.00 | |
Mar2023 | ₹1.45 Cr | 0.00 | |
Mar2022 | ₹1.45 Cr | -92.68 | |
Mar2021 | ₹20 Cr | -58.94 | |
Mar2020 | ₹48 Cr | - |
Compare Contingent Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹9,118.4 Cr | 1.1% | -26.3% | 34.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 1.1% |
-26.3% |
34.1% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses